Pathological Changes of the Visual Analyzer in Metabolic Syndrome
DOI:
https://doi.org/10.51699/ijhsms.v2i10.2714Keywords:
metabolic syndrome, retina, retinopathyAbstract
Metabolic syndrome is becoming a worldwide challenge for medicine and public health, as its prevalence has been increasing over the years. Age-related eye diseases, which are the leading cause of blindness worldwide and visual impairment in developed countries, are also on the rise due to an aging population. It has been shown that many of the individual components of the metabolic syndrome are associated with these eye diseases. However, the relationship of metabolic syndrome with eye diseases is not clear. In this review, we examined the links between metabolic syndrome and some eye diseases in the population. We also examined the relationship of individual components of the metabolic syndrome with eye diseases due to a lack of research in this area. In addition, we have also summarized the current understanding of the etiological mechanisms of how metabolic syndrome or individual components lead to these eye diseases. With the increasing amount of data on such associations, it may be important to identify patients who are at risk of developing metabolic syndrome, since rapid treatment and intervention can potentially reduce the risk of developing certain eye diseases.
Downloads
References
Zhao Y, Yang K, Wang F, Liang Y, Peng Y, Shen R, et al. Associations between metabolic syndrome and syndrome components and retinal microvascular signs in a rural Chinese population: the Handan Eye Study. Graefes Arch Clin Exp Ophthalmol Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2012;250:1755–63
Saito K, Nagao Y, Yamashita H, Kawasaki R. Screening for retinal vessel caliber and its association with metabolic syndrome in Japanese adults. Metab Syndr related Disor 2011;9:427–32.
Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, Klein BE, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 2004;45:2949–54.
Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, Tano Y, et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 2008;92:161–6.
Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma 2004;13:319–26.
Chou CF, Cotch MF, Vitale S, Zhang X, Klein R, Friedman DS, et al. Age-related eye diseases and visual impairment among U.S. adults. Am J Prev Med 2013;45:29–35.
Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 2006;113:1354–62.
Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP, et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology 2008;115:227–32.
Zhao D, Cho J, Kim MH, Friedman DS, Guallar E. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology 2015;122:72–8.
Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology 2006;113:1081–6.
El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Moharram OA, Kangave D. Retinopathy as a predictor of other diabetic complications. Int Ophthalmol 2001;24:1–11.
Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002;25:859–64.
Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R.
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995;38:599–603.
Villar G, Garcia Y, Goicolea I, Vazquez JA. Determinants of development of microalbuminuria in normotensive patients with type 1 and type 2 diabetes. Diabete Metab 1999;25:246–54.
Welinder LG, Riis AH, Knudsen LL, Thomsen RW.Diabetes, glycemic control and risk of medical glaucoma treatment: a population-based case-control study. Clin Epidemiol 2009;1:125–31.
Stojanov O, Stokic E, Sveljo O, Naumovic N. The influence of retrobulbar adipose tissue volume upon intraocular pressure in obesity. Vojnosanit Pregl 2013;70:469–76. 2013/06/26, medical and pharmaceutical review
Ramdas WD, Wolfs RC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. Lifestyle and risk of developing openangle glaucoma: the Rotterdam study. Arch Ophthalmol 2011;129:767–72. 2011/02/16.
Vajaranant TS, Nayak S, Wilensky JT, Joslin CE. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol 2010;21:91–9.
Gasser P, Stumpfig D, Schotzau A, Ackermann-Liebrich U, Flammer J. Body mass index in glaucoma. J Glaucoma 1999;8:8–11. 1999/03/20.
Szaflik JP, Rusin P, Zaleska-Zmijewska A, Kowalski M, Majsterek I, Szaflik J. Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat Res 2010;697:19–23.
Bulpitt CJ, Hodes C, Everitt MG. Intraocular pressure and systemic blood pressure in the elderly. Br J Ophthalmol 1975;59:717–20.
Shiose Y, Kawase Y. A new approach to stratified normal intraocular pressure in a general population. Am J Ophthalmol 1986;101:714–21.
Wolf S, Arend O, Sponsel WE, Schulte K, Cantor LB, Reim M. Retinal hemodynamics using scanning laser ophthalmoscopy and hemorheology in chronic openangle glaucoma. Ophthalmology 1993;100:1561–6.
Perejda AJ, Uitto J. Nonenzymatic glycosylation of collagen and other proteins: relationship to development of diabetic complications. Coll Relat Res 1982;2:81–8.
Reddy PY, Giridharan NV, Reddy GB. Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats. Mol Vis 2012;18:495–503.
De Castro DK, Punjabi OS, Bostrom AG, Stamper RL, Lietman TM, Ray K, et al. Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol 2007;35:506–13.
Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1992;33:2224–8.
Lee JS, Choi YR, Lee JE, Choi HY, Lee SH, Oum BS. Relationship between intraocular pressure and systemic health parameters in the Korean population. Korean J Ophthalmol: KJO 2002;16:13–9.
Mori K, Ando F, Nomura H, Sato Y, Shimokata H. Relationship between intraocular pressure and obesity in Japan. Int J Epidemiol 2000;29:661–6.
Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol 1997;115:1572–6.
Yoshida M, Ishikawa M, Kokaze A, Sekine Y, Matsunaga N, Uchida Y, et al. Association of life-style with intraocular pressure in middle-aged and older Japanese residents. Jpn J Ophthalmol 2003;47:191–8.
Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003;114:638–46.
Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 2005;123:458–63.
Sarah B Wang, Paul Mitchell, Adam J H Plant, Kevin Phan, Gerald Liew,
Aravinda Thiagalingam, George Burlutsky, Bamini Gopinath1 Metabolic syndrome and retinal microvascular calibre in a high cardiovascular disease risk cohort/Br J Ophthalmol 2016;100:1041-1046.doi:10.1136/bjophthalmol-2015-307637
Ja K. Gu, Luenda E. Charles, Penelope Allison, John M. Violanti, Michael E. Andrew Association Between the Metabolic Syndrome and Retinal Microvascular Diameters Among Police Officers J Occup Environ Med. Author manuscript; available in PMC 2023 June 19.
